Differential effects of polyunsaturated fatty acids on sterol synthesis rates in adult and fetal tissues of the hamster: consequence of altered sterol balance

Kara E. Schmid and Laura A. Woollett

Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0529

Submitted 13 May 2003 ; accepted in final form 17 July 2003


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Cholesterol is necessary for the proper growth and development of the fetus. Consequently, disruptions in cholesterol biosynthesis lead to abnormal fetal development. It has been shown that in cells exposed to polyunsaturated fatty acids (PUFA), the expressions of genes and activities of enzymes involved in cholesterol synthesis are reduced. Similarly, we found that adult male hamsters fed PUFA-enriched diets had an {approx}60% reduction in in vivo hepatic sterol synthesis rates. If fetal tissues respond to PUFA in the same manner as do adult livers, then maternal dietary PUFA could lead to a reduction in fetal sterol synthesis rates and possibly abnormal development. To investigate the impact of maternal dietary fatty acids on fetal sterol synthesis rates, female hamsters were fed diets enriched in various fatty acids before and throughout gestation. In vivo sterol synthesis rates were measured in fetuses at mid- and late gestation. At both gestational stages, dietary PUFA had no effect on fetal sterol synthesis rates. This lack of effect was not a consequence of a lack of PUFA enrichment in fetal fatty acids or the lack of PUFA receptor expression in the fetus. We hypothesize that the fetus may experience a dysregulation of sterol synthesis as the result of the fetus being in a negative sterol balance; the PUFA-induced suppression of sterol synthesis in the adult male hamster liver was ablated by creating a net negative sterol balance across the adult hepatocyte.

cholesterol; placenta; yolk sac; fetus; gestation


DIETARY FATTY ACIDS CAN HAVE profound effects on sterol metabolism in the adult. In the hamster, an animal that responds to dietary components in a manner similar to a human (9, 40), dietary saturated fatty acids (SFA) elevate plasma low-density lipoprotein cholesterol (LDL-C) concentrations by increasing LDL-C production rates and decreasing LDL receptor levels (52-54). In contrast, dietary polyunsaturated fatty acids (PUFA) reduce plasma LDL-C concentrations by decreasing LDL-C production rates and increasing LDL receptor levels (54). From in vitro studies, it is known that the mechanisms responsible for the various effects of PUFA include the activation of various nuclear receptors, such as the peroxisome proliferator-activated receptors (PPAR) (13, 25) and liver X receptors (LXR) (reviewed in Ref. 21), and the manipulation of levels of proteins responsible for regulation of sterol metabolism, including the sterol regulatory element binding proteins 1 and 2 (SREBPs) (reviewed in Refs. 21 and 55). One of the effects of PUFA in rapidly dividing cells in vitro is the suppression of SREBP-2 levels (55). Assuming that SREBP-2 is a major regulator of sterol synthesis (18), reduction of expression levels could lead to a suppression of sterol synthesis in rapidly dividing cells.

Although the ability to decrease sterol synthesis rates would be advantageous to the adult, suppression of sterol synthesis rates in rapidly growing embryonic or fetal tissues could be quite detrimental since cholesterol is absolutely necessary for their proper development (22, 36, 42). Fetal cholesterol is required for membrane formation, hormone synthesis, and development of the central nervous system through activation of Sonic hedgehog (34). Consequently, fetuses with disrupted cholesterol biosynthesis experience abnormal development, as demonstrated by rodents given cholesterol synthesis inhibitors (7, 35) and individuals with Smith-Lemli-Opitz syndrome (20, 38, 42). Patients with this syndrome have abnormally low tissue and plasma cholesterol concentrations and numerous congenital birth defects, including craniofacial abnormalities, limb malformation, congenital heart defects, and holoprosencephaly, in the most severe cases (22, 42).

The purpose of the present study was to determine the impact of dietary PUFA on in vivo sterol synthesis rates in a rapidly growing tissue, the fetus, by using an animal model that responds to dietary factors as do humans (40). Previous studies that examined the role of PUFA in fetal development (29) used an animal model, the rat, that has exceedingly high hepatic and whole body sterol synthesis rates compared with the human (9) and does not express some receptors for PUFA, specifically the PPARs, during early/midgestation (2, 5). Also, we proposed to elucidate the mechanism responsible for the response to PUFA in the fetal tissues. Hamsters were fed diets enriched in medium-chain triglycerides (MCT) as a control group and either PUFA or SFA. Both male and female hamsters were used. Sterol synthesis rates were measured in the adult male hamster liver, because of its sensitivity to various dietary components (9, 40), and in the fetus and extraembryonic fetal tissues. Dietary PUFA resulted in an {approx}60% decrease in sterol synthesis rates in the adult liver. In contrast, fetal sterol synthesis rates were not suppressed by PUFA fed to the pregnant dam. The lack of effect was not due to a lack of PUFA enrichment of the fetal fatty acid pool or to a lack of expression of fatty acid receptors in the hamster fetus. Interestingly, the adult could be converted to also become nonresponsive to dietary PUFA by creating a net negative sterol balance across the hepatocyte. Thus the cause of the dysregulation of sterol synthesis rates in the fetus could be at least partially due to a negative sterol balance across the fetus.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Animals and diets. Male and female hamsters (Charles River Laboratories, Kingston, NJ) were housed in colony cages and exposed to a 14-h light/10-h dark cycle before and during the studies. Male hamsters were fed diets ad libitum for 3 wk before each study, and female hamsters were fed diets ad libitum for 3 wk before mating and throughout gestation. Pregnant dams were studied at 11 and 14 days of gestation; the hamster has a gestational period of 15.5 days (51).

Two different sets of diets were used for the studies. For the first set of diets, adult males and females were fed diets consisting of ground rodent chow (7102CM; Harlan Teklad, Madison, WI) mixed with 15% (wt/wt) dietary oil and 0.05% vitamin E (ICN Biomedicals, Aurora, OH) and containing an inherent cholesterol concentration of 0.001% (wt/wt); all ground rodent chow contains 0.001-0.01% inherent levels of cholesterol. Three different oils were added to the diets. The control diet contained MCT oil (Mead Johnson, Evansville, IN) comprised mainly of caprylic acid (8:0) and capric acid (10:0). MCT was fed to animals as the control diet to 1) have an equal distribution of calories between fat, protein, and carbohydrate in all three diets and 2) because the addition of MCT oil to chow has been shown to have no effect on sterol synthesis rates in vivo compared with diets containing 100% plain chow and thus makes an appropriate control when studying the effects of oil vs. no oil (52). Experimental diets contained either corn oil as a source of PUFA, comprised primarily of linoleic acid (18:2), or hydrogenated coconut oil as a source of SFA, comprised primarily of lauric acid (12:0). For the second set of diets, males were fed 15% oil and 0.05% vitamin E plus 3% (wt/wt) cholestyramine (a gift from Dr. Deborah Diersen-Schade, Mead Johnson Nutritionals). The cholestyramine powder was mixed with the ground chow before the addition of the oils. All diets were made fresh every 2-3 wk and stored under nitrogen at 4°C. The Institutional Animal Care and Use Committee of the University of Cincinnati approved all protocols.

In vivo sterol synthesis rates. Pregnant female and adult male hamsters were injected intraperitoneally with 50 mCi 3H2O (3, 8, 51). After 1 h, animals were anesthetized and exsanguinated, and adult livers, placentas, yolk sacs, and fetuses were isolated. After saponification of tissues, the digitonin-precipitable sterols were isolated and assayed for 3H (8). The rates of sterol synthesis are presented as nanomoles of 3H2O incorporated into sterol per hour per gram of tissue.

Cholesterol concentrations. Placentas, yolk sacs, and fetuses were isolated and saponified. The mass of cholesterol was measured by gas liquid chromatography (GLC) using stigmastanol as an internal standard (46, 51). Data are presented as milligrams of cholesterol per gram of tissue.

Tissue fatty acid compositions. Maternal livers, placentas, yolk sacs, and fetuses at 11 days gestation were isolated and pooled. Lipids were extracted, extracts were dried under N2 and saponified, and the fatty acids were methylesterified (30). Fatty acids were separated by GLC (41) and are presented as a percentage of total fatty acid content.

Immunodetection of PPAR proteins. At 11 days of gestation, fetuses were isolated from the extraembryonic tissue and snap frozen in liquid nitrogen. At 14 days of gestation, fetuses were isolated and the fetal peritoneal organs were removed and snap frozen in liquid nitrogen. The tissues were stored at -70°C for 1-2 wk. PPAR protein expression was determined according to Kremarik-Bouillaud et al. (26). Proteins (200 µg) were separated by electrophoresis in an 8% SDS-PAGE gel and transferred to nitrocellulose. Membranes were incubated with antibodies directed against either PPAR{alpha}, -{beta}, or -{gamma} (Santa Cruz Biotechnology sc-9000, sc-7197 and sc-7196, respectively) at dilutions of 1:200 ({alpha} and {gamma}) or 1:500 ({beta}). The proteins were detected by incubation with a horseradish peroxidase-conjugated goat anti-rabbit antibody (Boehringer-Mannheim, Indianapolis, IN) and visualized with ECL Plus (Amersham Pharmacia, Piscataway, NJ).

Statistics. Data are presented as means ± 1SE. Differences between mean values of MCT-fed animals and the PUFA- or SFA-fed groups were tested for statistical significance (P < 0.05) by using the two-tailed unpaired Student's t-test.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
PUFA decrease the expression of enzymes and proteins necessary for cholesterol synthesis in vitro and during acute feedings (23, 55, 56). To test the role of chronically fed PUFA on sterol synthesis rates in vivo in an animal with hepatic sterol synthesis rates that parallel the human (9), male hamsters were fed diets enriched in MCT, PUFA, or SFA, and hepatic sterol synthesis rates were measured. In vivo hepatic sterol synthesis rates were decreased 58% (P < 0.05) in hamsters fed PUFA and in the presence of a very low inherent level of dietary cholesterol compared with hamsters fed MCT (Fig. 1). Dietary SFA had no effect on hepatic sterol synthesis rates compared with hamsters fed MCT.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Fatty acid effects on hepatic sterol synthesis rates in the adult. Male hamsters were fed diets containing 15% (wt/wt) of medium-chain triglycerides (MCT; control), polyunsaturated fatty acids (PUFA; corn oil), or saturated fatty acids [SFA; hydrogenated coconut oil (HCO)] for 3 wk. Hamsters were injected with 3H2O, and tissue samples were collected 1 h later. The amount of digitonin-precipitable sterols present in each sample was measured. Data are presented as nanomoles of 3H2O converted to sterol per hour per gram of liver. Values are means ± 1SE for data obtained in 3 animals. Significant differences (*P < 0.05) between dietary fatty acids are shown.

 

Before the studies in which dams were fed MCT, PUFA, or SFA, tests were completed to determine which level of oil could be added to diets to ensure normal fetal development. Females were fed 0, 5, 10, and 15% MCT before and during gestation. At 11 days of gestation, fetal weights and cholesterol concentrations were measured. There was no difference in the weight or cholesterol concentration in fetuses of dams fed any diet (data not shown). For the remainder of the studies, females were fed 15% dietary oil.

Sterol synthesis rates and concentrations were measured initially in fetuses of dams fed MCT, PUFA, and SFA before and throughout gestation. In early/midgestation, sterol synthesis rates were greatest in the yolk sac (2,673 ± 237 nmol/h per gram), next greatest in the fetus (774 ± 47 nmol/h per gram), and lowest in the placenta (315 ± 18 nmol/h per gram) of MCT-fed dams. In contrast to rates in the adult, dietary PUFA had no effect on sterol synthesis rates in any of the fetal tissues (Fig. 2, A-C). As with PUFA, dietary SFA had no effect on sterol synthesis rates in the placenta and fetus. However, in contrast to PUFA, sterol synthesis rates were reduced 22% (P < 0.05) in the yolk sac of dams fed SFA compared with MCT-fed dams (Fig. 2B). Tissue cholesterol concentrations were similar regardless of dietary oil fed to the dam (Fig. 2, D-F). By late gestation, sterol synthesis rates decreased 76% in the yolk sac and 53% in the fetus of control dams and remained relatively constant in the placenta (Fig. 3, A-C) compared with tissues at midgestation. Neither dietary PUFA nor SFA had an effect on sterol synthesis rates in the fetal tissues, including the yolk sac, at this late stage of gestation. As one might expect, cholesterol concentrations were similar in all fetal tissues from dams fed any of the diets (Fig. 3, D-F); cholesterol concentration increased {approx}25% in the placentas and yolk sacs as gestation progressed.



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2. Fatty acid effects on fetal tissue sterol synthesis rates and cholesterol concentrations at 11 days gestation. Female hamsters were fed diets containing 15% (wt/wt) MCT oil, PUFA, or SFA for 3 wk before gestation and throughout gestation until the day of the study. At 11 days gestation, the placentas (A and D), yolk sacs (B and E), and fetuses (C and F) were removed and sterol synthesis rates (A-C) and cholesterol concentrations (D-F) were measured. Sterol synthesis rates were measured as described in Fig. 1. Data are presented as nanomoles of 3H2O converted to sterol per hour per gram of tissue. Cholesterol concentrations were determined by gas liquid chromatography (GLC). Data are presented as milligrams of cholesterol per gram of tissue. Values are means ± 1SE for data obtained in 7 animals. Significant differences (*P < 0.05) between dietary fatty acids are shown.

 


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3. Fatty acid effects on fetal tissue sterol synthesis rates and cholesterol concentrations at 14 days gestation. Female hamsters were fed diets containing 15% (wt/wt) MCT oil, PUFA, or SFA for 3 wk before gestation and throughout gestation until the day of the study. At 14 days gestation, the placentas (A and D), yolk sacs (B and E), and fetuses (C and F) were removed and sterol synthesis rates (A-C) and cholesterol concentrations (D-F) were measured. Sterol synthesis rates were measured as described in Fig. 1. Data are presented as nanomoles of 3H2O converted to sterol per hour per gram of tissue. Cholesterol concentrations were determined by GLC. Data are presented as milligrams of cholesterol per gram of tissue. Values are means ± 1SE for data obtained in 6 animals fed control, 5 animals fed PUFA, and 3 animals fed SFA.

 

The lack of effect of dietary PUFA on fetal sterol synthesis rates could be due to the fact that 1) the fetus did not become enriched in the maternal dietary fatty acids, 2) PUFA receptors were not expressed during gestation in the hamster since they were not expressed in midgestation of the mouse or rat (2, 5), or 3) the fetus has a dysregulation of sterol synthesis compared with the adult in steady state. Each of these three mechanisms was examined sequentially.

The fatty acid compositions of fetal and maternal tissues were analyzed first to determine if the fetal tissues became enriched in maternal dietary fatty acids (Table 1). Only the most prevalent fatty acids are represented. The maternal livers of control dams contained primarily palmitic (16:0) and stearic acids (18: 0), whereas the fetuses had primarily the 16:0 fatty acid. When dams were fed PUFA, the relative amount of the linoleic acid (18:2) increased by 33% compared with amounts in MCT-fed dams. The fetuses in the PUFA-fed dams had a 44% increase in the enrichment of the 18:2 fatty acid compared with fetuses of dams fed MCT. In livers of SFA-fed dams, there were 333 and 10% increases in the myristic (14:0) and palmitic acids, respectively, compared with MCT-fed dams. Correspondingly, the fetuses of dams fed SFA had a 59% increase of the 14:0 fatty acid. Thus the fetuses did become enriched in maternal dietary fatty acids.


View this table:
[in this window]
[in a new window]
 
Table 1. Fatty acid composition of maternal and fetal tissues

 

PUFA can affect the nuclear receptors PPAR and LXR and modify processing of SREBPs in the adult (21). Both the LXR and SREBPs are expressed by midgestation in other rodent models (10, 49, 50), whereas PPARs are not expressed in fetuses from midgestation in the mouse and rat (2, 5). Therefore, the expression profiles of all three PPARs ({alpha}, {beta}, and {gamma}) were examined in fetuses of the hamster at mid- and late gestation. Contrary to what occurs in mouse and rat, PPAR isoforms were expressed by midgestation in the hamster and were still present at late gestation (Fig. 4).



View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4. Peroxisome proliferator-activated receptor (PPAR) expression in the fetus at 11 and 14 days gestation. Female hamsters were fed diets containing 15% (wt/wt) MCT oil, PUFA, or SFA for 3 wk before gestation and throughout gestation until the day of the study. At 11 and 14 days gestation, fetuses and fetal peritoneal organs, respectively, were removed and evaluated for the expression of PPAR{alpha}, -{beta}, and -{gamma} by immunoblot analysis. Bands correspond to 3 pooled samples. The apparent molecular weights of the immunoreactive bands correspond to published sizes for the PPAR isoforms (52-56 kDa) and are shown in relation to the 47-kDa band of a molecular weight marker.

 

The third possible mechanism for the lack of effect of PUFA in the fetus is that there is a dysregulation of sterol synthesis in the fetus compared with the adult. Previous studies have shown that the responsiveness of an animal to dietary cholesterol can be changed by manipulating sterol balance across the hepatocyte (Refs. 43 and 44 and Woollett and Dietschy, unpublished data). To test if a difference in sterol balance could change the responsiveness of an animal to dietary PUFA, adult male hamsters were placed into a negative sterol balance by feeding animals cholestyramine plus a control oil (MCT), PUFA, or SFA (43); adult male hamsters were studied because we demonstrated that sterol synthesis rates would become suppressed in these animals when fed PUFA (Fig. 1). All animals fed cholestyramine had a marked increase ({approx}3.5-fold) in hepatic sterol synthesis rates, regardless of dietary fatty acid. Furthermore and even more importantly, dietary PUFA did not result in a decrease in hepatic sterol synthesis rates compared with rates in the MCT-fed animals when cholestyramine was added to the diets (Fig. 5.).



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5. Fatty acid effects on induced hepatic sterol synthesis rates in the adult. Male hamsters were fed diets containing 15% (wt/wt) MCT oil, PUFA, or SFA with the addition of 3% cholestyramine for 3 wk. Sterol synthesis rates were measured as described in Fig. 1. Data are presented as nanomoles of 3H2O converted to sterol per hour per gram of liver. Values are means ± 1SE for data obtained in 4 animals.

 


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
These studies are the first to show that sterol synthesis rates in adult male livers and fetal tissues respond differently to PUFA. When the adult liver and fetal tissues of the hamster are enriched with PUFA, hepatic sterol synthesis rates in the adult decrease {approx}60%, whereas fetal tissue synthesis rates remain unchanged. This lack of effect of dietary PUFA implies a difference in the regulation of sterol synthesis in fetal tissues compared with adults. Several mechanisms could be involved in the inability of PUFA to regulate sterol synthesis rates in fetal tissues.

First, for fatty acids to have an effect within a tissue, the fatty acid must become incorporated into the lipid pool of the tissue. Even though the fetus does not come in direct contact with the maternal circulation, there are various fatty acid transporters within the placenta that will transport fatty acids to the fetus. In fact, the preferred substrate for these placental fatty acid transporters are PUFA (11, 16) because {approx}50% of the fatty acids within the developing brain consist of the long-chain, maternal-derived PUFA (15). Similar to that which occurs in the rat (29), there was a significant increase in the enrichment of fetal linoleic acid when dams were fed PUFA-containing diets; the degree of enrichment within the hamster fetus was slightly greater than that which occurs in the liver of the pregnant dam. Thus the lack of effect of PUFA on sterol synthesis rates was not due to a lack of enrichment of PUFA in fetal tissues.

Second, for the PUFA to exert an effect, the receptors or transcription factors that PUFA affect in adult cells or cell culture must be expressed in the fetus. Recently, PUFA have been shown to activate the nuclear receptors PPAR and LXR as well as affect the processing of SREBP. Because it is known that LXR and SREBP are expressed in murine fetal tissues during gestation (10, 49, 50) and that PPARs are not expressed in early/midgestation fetal tissues of the mouse and rat (2, 5), it was necessary to determine whether the PPARs are expressed in the hamster fetus. A lack of PPARs in the fetus could explain the lack of effect of PUFA. In contrast to other rodents, the hamster fetus expresses all three isoforms of the PPARs by midgestation. Thus the lack of effect of PUFA on fetal sterol synthesis rates is not due to a lack of expression of the PPARs. The various roles of the different forms of the PPARs in the fetus are unknown; murine fetal growth can continue in the absence of PPAR{alpha} (27), possibly as the result of PPAR{delta} having similar, redundant functions to PPAR{alpha} (31), and is abnormal in the absence of PPAR{gamma} (1). It should be noted that these results do not rule out the possibility that these receptors are not active in the fetus or are under different regulation. Also, other receptors or transcription factors that PUFA affect may not be expressed in the fetal period.

Third, the sterol balance of the fetus or fetal tissues could be different from that of the control adult. A neutral sterol balance is depicted by an equal amount of cholesterol leaving and entering the regulatory pool of cholesterol (or the body) and is indicative of a steady state, whereas a negative sterol balance is one in which there is more cholesterol leaving vs. entering the regulatory pool of cholesterol (or the body). In the adult, a net negative sterol balance can be induced with bile acid sequestrates, such as cholestyramine, and is denoted by high hepatic sterol synthesis rates (43, 44). The fetus is unique in that it is growing rapidly and has a high requirement for cholesterol; thus it is not in a steady state as is the adult. During this rapid growth rate, if the fetus uses cholesterol as soon as it is synthesized or accrued for membranes, hormones, or signaling molecules, then the fetus could be in a negative sterol balance. Since the fetal sterol synthesis rate and requirement for sterol are both high, we hypothesize that the fetus and extraembryonic fetal tissues exist in a negative sterol balance, whereas the control adult is in a neutral sterol balance.

Previous studies (9, 43, 44) have shown that the responsiveness of an animal to dietary components is at least partially dependent on sterol balance. Most of the previous studies have examined the effect of exogenous cholesterol on sterol balance. For example, a male hamster that responds to dietary cholesterol can be converted to one that does not respond simply by putting the animal into a net negative sterol balance (Refs. 43 and 44 and Woollett and Dietschy, unpublished data). Another indication of how an animal will respond to dietary cholesterol is the rate of sterol synthesis within the liver. Animals that have higher baseline synthesis rates seem to be less responsive to exogenous sterol (9). Rats have markedly elevated hepatic sterol synthesis rates compared with the hamster (9) and are much more unresponsive to dietary cholesterol (17). Additionally, cynomolgus monkeys with higher hepatic sterol synthesis rates are more unresponsive to exogenous cholesterol compared with counterparts with lower hepatic sterol synthesis rates (47). The fact that one could convert the male hamster that responds to dietary PUFA into one that does not respond simply by changing net sterol balance implies that responsiveness to exogenous factors may not be limited to just dietary cholesterol but may include other compounds that could affect sterol balance, such as fatty acids (6). Further support for the lack of effect of PUFA during a negative sterol balance is that nonpregnant females have different sterol synthesis rates when fed 15% MCT or PUFA (908 ± 59 vs. 612 ± 110 nmol/h per gram for MCT- vs. PUFA-fed females; P = 0.07, n = 3). However, in late gestation, when females are in a negative sterol balance, sterol synthesis rates are similar in pregnant dams fed either diet (3,311 ± 990 vs. 3,568 ± 256 nmol/h per gram for MCT- vs PUFA-fed females; n = 3). The differences in hepatic sterol synthesis rates and responsiveness to cholesterol could be at least part of the explanation for any differences in responsiveness to dietary fatty acids obtained between different rodent models (24, 56) or studies done in the same animal species, including humans, but fed different inherent levels of cholesterol (14, 28, 39).

A change in the sterol balance across the adult liver results in changes in expression patterns of various proteins, including the SREBPs (32, 37). Under normal conditions, cholesterol synthesis is regulated primarily by SREBP-2 and fatty acid synthesis is regulated by SREBP-1c and -1a; however, when expressed at elevated levels, SREBP-1c can affect sterol synthesis rates (18). The SREBP levels can be made unresponsive to regulation under different conditions, such as overexpression of the SREBP cleavage-activating protein (SCAP) or continuous processing of SREBP to the mature form (19, 57, 58). In fact, when processing of SREBP was mutated to become continuous, the ability of PUFA to reduce SREBP-activated gene expression was lost (55).

Even though it is possible that SREBP activation and expression are different during times of negative or neutral sterol balance, recent studies (4, 12, 33, 48) have suggested that factors in addition to SREBP levels may be involved in the regulation of lipid synthesis within tissues. In one such study (12), hamsters were fed various fatty acids, and fatty acid synthesis rates, SREBP-1 mRNA, and mature SREBP-1 levels were measured. The authors found a suppression of fatty acid synthesis in animals fed PUFA with no change in SREBP-1 mRNA or mature protein levels. In a second recent study (48), a novel isoform of SREBP-2 isolated from spermatogenic cells was found not to be sensitive to sterol regulation. This protein is synthesized as a soluble transcription factor that is constitutively active and bypasses the sterol-regulated proteolytic activation of SREBP.

Interestingly, at 11 days of gestation there was a slight decrease in sterol synthesis rates in the yolk sacs of dams fed saturated fatty acids. This appeared to be a transient effect because there was no difference in synthesis rates by 14 days of age. Because the cholesterol concentration of the tissue was similar to those measured in tissues of dams fed other fatty acids, the slight decrease could have occurred to regulate differences in uptake of exogenous maternal lipoproteins (51).

In conclusion, these data demonstrate that PUFA enrichment inhibits sterol synthesis rates in the adult male liver but not in the fetus, indicating a difference between fetal and adult regulation of sterol synthesis rates. The mechanism for this difference appears to be at least partly due to a negative sterol balance that exists across the fetus, or possibly any rapidly growing tissue. These are important data since the consumption of PUFA has increased recently as the result of dietary recommendations by the American Heart Association. An inhibition of sterol synthesis rates by PUFA in the fetus of women consuming a PUFA-enriched cholesterol-lowering diet would have severe consequences due to the essential requirement of cholesterol for normal development. Thus it is a benefit for fetal development that fetal sterol synthesis rates are unresponsive to regulation by dietary PUFA.


    DISCLOSURES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
This research was supported by grants HD-34089 and DK-59630 from the National Institutes of Health.


    ACKNOWLEDGMENTS
 
We thank Dr. Donald C. Beitz and Michelle Bohan for the analysis of fatty acid composition.


    FOOTNOTES
 

Address for reprint requests and other correspondence: L. A. Woollett, Dept. of Pathology and Laboratory Medicine, Univ. of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 (E-mail: laura.woollett{at}uc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, and Evans RM. PPAR gamma is required for placental, cardiac and adipose tissue development. Mol Cell 4: 585-595, 1999.[ISI][Medline]
  2. Beck F, Plummer S, Senior PV, Byrne S, Green S, and Brammar WJ. The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat. Proc R Soc Lond B Biol Sci 247: 83-87, 1992.[ISI][Medline]
  3. Belknap WM and Dietschy JM. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. J Clin Invest 82: 2077-2085, 1988.[ISI][Medline]
  4. Botolin D and Jump DB. Selective proteolytic processing of rat hepatic sterol regulatory element binding protein-1 (SREBP-1) and SREBP-2 during postnatal development. J Biol Chem 278: 6959-6962, 2003.[Abstract/Free Full Text]
  5. Braissant O and Wahli W. Differential expression of peroxisome proliferator-activated receptor-{alpha}, -{beta}, and -{gamma} during rat embryonic development. Endocrinology 139: 2748-2754, 1998.[Abstract/Free Full Text]
  6. Daumerie CM, Woollett LA, and Dietschy JM. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc Natl Acad Sci USA 89: 10797-10801, 1992.[Abstract]
  7. Dehart BD, Lanoue L, Tint GS, and Sulik KK. Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome. Am J Med Genet 68: 328-337, 1997.[ISI][Medline]
  8. Dietschy JM and Spady DK. Measurement of rates of cholesterol synthesis using tritiated water. J Lipid Res 25: 1469-1476, 1984.[Abstract]
  9. Dietschy JM, Turley SD, and Spady DK. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 34: 1637-1659, 1993.[ISI][Medline]
  10. Diomede L, Salmona M, Albani D, Bianchi M, Bruno A, Salmona S, and Nicolini U. Alteration of SREBP activation in liver of trisomy 21 fetuses. Biochem Biophys Res Commun 260: 499-503, 1999.[ISI][Medline]
  11. Dutta-Roy AK. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr 71: 315S-322S, 2000.[Abstract/Free Full Text]
  12. Field FJ, Born E, and Mathur SN. Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of sterol regulatory element-binding protein-1 expression. J Lipid Res 44: 1199-1208, 2003.[Abstract/Free Full Text]
  13. Forman BM, Chen J, and Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997.[Abstract/Free Full Text]
  14. Glatz JFC and Katan MB. Dietary saturated fatty acids increase cholesterol synthesis and fecal steroid excretion in healthy men and women. Eur J Clin Invest 23: 648-655, 1993.[ISI][Medline]
  15. Gurr Fats M. In: Human nutrition and Dietetics, edited by Garrow JS and James WPT. Edinburgh, UK: Churchill & Livingstone, 1993, p. 77-102.
  16. Haggarty P, Page K, Abramovich DR, Ashton J, and Brown D. Long-chain polyunsaturated fatty acid transport across the perfused human placenta. Placenta 18: 635-642, 1997.[ISI][Medline]
  17. Horton JD, Cuthbert JA, and Spady DK. Regulation of hepatic 7a-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J Biol Chem 270: 5381-5387, 1995.[Abstract/Free Full Text]
  18. Horton JD, Goldstein JL, and Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131, 2002.[Free Full Text]
  19. Hua X, Nohturfft A, Goldstein JL, and Brown MS. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage activating protein (SCAP). Cell 87: 415-426, 1996.[ISI][Medline]
  20. Irons M, Elias ER, Salen G, Tint GS, and Batta AK. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341: 1414, 1993.[ISI][Medline]
  21. Jump DB. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13: 155-164, 2002.[ISI][Medline]
  22. Kelley RI. Inborn errors of cholesterol biosynthesis. Adv Pediatr 47: 1-52, 2000.[Medline]
  23. Kim HJ, Miyazaki M, Man WC, and Ntambi JM. Sterol regulatory element-binding proteins (SREBPs) as regulators of lipid metabolism. Polyunsaturated fatty acids oppose cholesterol-mediated induction of SREBP-1 maturation. Ann NY Acad Sci 967: 34-42, 2002.[Abstract/Free Full Text]
  24. Kim HJ, Takahashi M, and Ezaki O. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. J Biol Chem 274: 25892-25898, 1999.[Abstract/Free Full Text]
  25. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Wilson TM, Lenhard JM, and Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323, 1997.[Abstract/Free Full Text]
  26. Kremarik-Bouillaud P, Schohn H, and Dauca M. Regional distribution of PPAR beta in the cerebellum of the rat. J Chem Neuroanat 19: 225-232, 2000.[ISI][Medline]
  27. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, and Gonzalez FJ. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022, 1995.[Abstract]
  28. Mazier MJ and Jones PJ. Diet fat saturation and feeding state modulate rates of cholesterol synthesis in normolipidemic men. J Nutr 127: 332-340, 1997.[Abstract/Free Full Text]
  29. Miguel SG and Abraham S. Effect of maternal diet on fetal hepatic lipogenesis. Biochim Biophys Acta 424: 213-234, 1976.[ISI][Medline]
  30. Morrison WR and Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5: 600-608, 1964.[Abstract/Free Full Text]
  31. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL, and Kraus WE. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) a knock-out mice. J Biol Chem 277: 26089-26097, 2002.[Abstract/Free Full Text]
  32. Nohturfft A, DeBose-Boyd RA, Scheek S, Goldstein JL, and Brown MS. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci USA 96: 11235-11240, 1999.[Abstract/Free Full Text]
  33. Ntambi JM and Bene H. Polyunsaturated fatty acid regulation of gene expression. J Mol Neurosci 16: 273-278, 2001.[ISI][Medline]
  34. Porter JA, Young KE, and Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274: 255-259, 1996.[Abstract/Free Full Text]
  35. Roux C, Horvath C, and Dupuis R. Teratogenic action and embryo lethality of AY9944R: prevention by a hypercholesterolemia-provoking diet. Teratology 19: 35-38, 1979.[ISI][Medline]
  36. Roux C, Wolf C, Mulliez N, Gaoua W, Cormier V, Chevy F, and Citadelle D. Role of cholesterol in embryonic development. Am J Clin Nutr 71 Suppl: 1270S-1279S, 2000.[Abstract/Free Full Text]
  37. Shimomura I, Bashmakov Y, Shimano H, Horton JD, Goldstein JL, and Brown MS. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. Proc Natl Acad Sci USA 94: 12354-12359, 1997.[Abstract/Free Full Text]
  38. Smith DW, Lemli L, and Opitz JM. A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64: 210-217, 1964.[ISI]
  39. Spady DK and Dietschy JM. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest 81: 300-309, 1988.[ISI][Medline]
  40. Spady DK, Woollett LA, and Dietschy JM. Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr 13: 355-381, 1993.[ISI][Medline]
  41. Stewart J, Kaplan ML, and Beitz DC. Pork with a high content of polyunsaturated fatty acids lowers LDL cholesterol in women. Am J Clin Nutr 74: 179-187, 2001.[Abstract/Free Full Text]
  42. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, and Salen G. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330: 107-113, 1994.[Abstract/Free Full Text]
  43. Turley SD, Daggy BP, and Dietschy JM. Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia. J Cardiovasc Pharmacol 27: 71-79, 1996.[ISI][Medline]
  44. Turley SD, Daggy BP, and Dietschy JM. Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. Gastroenterology 107: 444-452, 1994.[ISI][Medline]
  45. Turley SD and Dietschy JM. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat. J Cardiovasc Pharmacol 2: 281-297, 1980.[ISI][Medline]
  46. Turley SD, Herndon MW, and Dietschy JM. Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster. J Lipid Res 35: 328-339, 1994.[Abstract]
  47. Turley SD, Spady DK, and Dietschy JM. Identification of a metabolic difference accounting for the hyper- and hyporesponder phenotypes of cynomolgus monkey. J Lipid Res 38: 1598-1611, 1997.[Abstract]
  48. Wang H, Liu F, Millette CF, and Kilpatrick DL. Expression of a novel, sterol-insensitive form of sterol regulatory element binding protein 2 (SREBP2) in male germ cells suggests important cell- and stage-specific functions for SREBP targets during spermatogenesis. Mol Cell Biol 22: 8478-8490, 2002.[Abstract/Free Full Text]
  49. Wilentz RE, Witters LA, and Pizer ES. Lipogenic enzymes fatty acid synthase and acetyl-co-enzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues. Ped Devel Path 3: 525-531, 2000.[ISI]
  50. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, and Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9: 1033-1045, 1005.
  51. Woollett LA. Origin of cholesterol in the fetal Golden Syrian hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol. J Lipid Res 37: 1246-1257, 1996.[Abstract]
  52. Woollett LA, Spady DK, and Dietschy JM. Regulatory effects of the saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor activity in the hamster. J Clin Invest 89: 1133-1141, 1992.[ISI][Medline]
  53. Woollett LA, Spady DK, and Dietschy JM. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentration in hamsters. Differential effects of fatty acid chain length. J Clin Invest 84: 119-128, 1989.[ISI][Medline]
  54. Woollett LA, Spady DK, and Dietschy JM. Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J Lipid Res 33: 77-88, 1992.[Abstract]
  55. Worgall TS, Sturley SL, Seo T, Osborne TF, and Deckelbaum RJ. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem 273: 25537-25540, 1998.[Abstract/Free Full Text]
  56. Xu J, Cho H, O'Malley S, Park JHY, and Clarke SD. Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. J Nutr 132: 3333-3339, 2002.[Abstract/Free Full Text]
  57. Yang J, Sato R, Goldstein JL, and Brown MS. Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2. Genes Dev 8: 1910-1919, 1994.[Abstract]
  58. Yang T, Goldstein JL, and Brown MS. Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP-SREBP exit from endoplasmic reticulum. J Biol Chem 275: 29881-29886, 2000.[Abstract/Free Full Text]




This Article
Abstract
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Schmid, K. E.
Articles by Woollett, L. A.
Articles citing this Article
PubMed
PubMed Citation
Articles by Schmid, K. E.
Articles by Woollett, L. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.